The Royal National Institute of Blind People (RNIB) has raised concerns about the rising number of people living with sight loss in the UK. They project that by 2035, an estimated 2.8 million people will experience sight loss, marking a 27% increase from current figures. Furthermore, the number of individuals with severe sight loss or those registered blind is expected to rise by 29%, from 298,000 in 2022 to 379,000 in 2035.
Diabetes is a significant cause of blindness, particularly due to a complication called diabetic retinopathy. High blood sugar levels damage the blood vessels in the retina, leading to vision impairment and, if untreated, complete loss of sight. Diabetic retinopathy often develops without symptoms, making regular eye tests crucial for early detection and treatment. With diabetes on the rise in the UK, the number of people at risk for diabetic-related blindness is increasing, emphasising the need for better eye care and monitoring for those managing the condition.
The RNIB warns that if no action is taken, the number of people with sight loss could double to more than four million by 2050. They are urging the UK Government to develop a national eye care plan to address these issues. At the same time, they are encouraging individuals to get regular eye tests every two years, which can help prevent avoidable sight loss and detect other health conditions such as diabetes, high blood pressure, and cholesterol-related problems.
AI-driven assistive technologies like RealSAM are also becoming increasingly important in supporting those with sight loss. By offering tools that enhance accessibility, such as voice-activated technology and screen readers, RealSAM can help people maintain independence in the face of these growing challenges. For more information, visit RNIB’s website or explore RealSAM’s solutions at RealSAM.co.uk.
